| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $1,121,081 ) |
| | 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01HL160927 | Fibroblast growth factor 1 prevents hyperlipidemia and atherosclerosis | 000 | 3 | NIH | 11/13/2023 | $488,331 |
| | 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01HL163003 | Mechanisms Contributing to Pregnancy-induced Cardiac Remodeling | 000 | 2 | NIH | 11/17/2023 | $486,191 |
| | 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01HL168198 | Role of the PEP cycle in cardiac fibrosis | 000 | 1 | NIH | 11/17/2023 | $523,760 |
| | 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R34MH128213 | A Pilot Investigation of Network-Informed Personalized Treatment for Eating Disorders versus Enhanced Cognitive Behavioral Therapy and Dynamic Mechanisms of Change | 001 | 3 | NIH | 11/30/2023 | $108,534 |
| | 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R34MH128213 | A Pilot Investigation of Network-Informed Personalized Treatment for Eating Disorders versus Enhanced Cognitive Behavioral Therapy and Dynamic Mechanisms of Change | 000 | 3 | NIH | 11/29/2023 | $211,275 |
| | 2024 | 2023 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | H79SM084409 | Mental Health Awareness Training for Caregivers, Caring Adults, and Community Organizations to Recognize and Respond to Young People at Risk for Mental Health Problems | 000 | 1 | SAMHSA | 10/13/2023 | $0 |
| | 2024 | 2023 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | H79SM084409 | Mental Health Awareness Training for Caregivers, Caring Adults, and Community Organizations to Recognize and Respond to Young People at Risk for Mental Health Problems | 000 | 1 | SAMHSA | 10/13/2023 | $0 |
| | 2024 | 2023 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | F31DK130609 | The role of PGC-1alpha in repeated low-dose cisplatin-induced kidney injury and the progression to chronic kidney disease | 000 | 2 | NIH | 11/2/2023 | -$28,436 |
| | 2024 | 2023 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01MH131633 | Longitudinal Personalized Dynamics Among Anorexia Nervosa Symptoms, Core Dimensions, and Physiology Predicting Suicide Risk | 000 | 1 | NIH | 12/6/2023 | $3,337 |
| | 2024 | 2023 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | CE152149 | Community Project Funding/Congressionally Directed Spending - Construction | 03 | 1 | HRSA | 12/4/2023 | $0 |
| | 2024 | 2023 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01MH129357 | Anxiety and Interoception Risk for Eating Disorders in Childhood | 000 | 1 | NIH | 10/26/2023 | $0 |
| | 2024 | 2023 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | CE152149 | Community Project Funding/Congressionally Directed Spending - Construction | 02 | 1 | HRSA | 11/16/2023 | $0 |
| | 2024 | 2023 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | CE152149 | Community Project Funding/Congressionally Directed Spending - Construction | 01 | 1 | HRSA | 11/9/2023 | $0 |
| | 2024 | 2023 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | UG1OD024954 | The Kentucky ECHO Pediatric IDeA Research Center (KE-PIRC) | 000 | 6 | NIH | 10/11/2023 | $0 |
| | 2024 | 2023 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | UG1HD107649 | Neonatal Opioid Withdrawal Syndrome (NOWS) in Kentucky: Improving Outcomes for Infants | 000 | 2 | NIH | 10/11/2023 | $0 |
| | 2024 | 2022 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | F31DE027585 | Exploitation of the host immune response by Aggregatibacter actinomycetemcomitans mediated by QseBC | 000 | 5 | NIH | 10/31/2023 | -$16,835 |
| | 2024 | 2022 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | F31AI147404 | Identification of a novel zinc acquisition system in Yersinia pestis | 000 | 3 | NIH | 10/31/2023 | -$4,747 |
| | 2024 | 2022 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | F31AA028423 | sEH Inhibition in Alcoholic Liver Disease: A Novel Therapeutic Strategy | 000 | 3 | NIH | 12/5/2023 | -$19,768 |
| | 2024 | 2022 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | U18TR003787 | A Handheld Microchip for GC analysis of breath to screen for COVID-19 | 001 | 2 | NIH | 11/23/2023 | $0 |
| | 2024 | 2022 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01AA023190 | Mechanisms of Probiotics in Alcoholic Liver Disease | 001 | 8 | NIH | 10/26/2023 | -$217,343 |
| | 2024 | 2021 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01AA023190 | Mechanisms of Probiotics in Alcoholic Liver Disease | 000 | 7 | NIH | 10/26/2023 | -$112,846 |
| | 2024 | 2021 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R21MH122368 | Characterization of clonal expansion in the CNS-restricted reservoir using HIV SMRTcap, a novel single molecule assay providing simultaneous resolution of proviral genomes and integration sites | 000 | 2 | NIH | 10/16/2023 | -$8,323 |
| | 2024 | 2021 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | OT2OD024898 | Functional Mapping with Lumbosacral Epidural Stimulation for Restoration of Bladder Function After Spinal Cord Injury | 000 | 1 | NIH | 10/30/2023 | $0 |
| | 2024 | 2021 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R21ES031510 | m6A Epitranscriptomics in Toxicant Associated Steatohepatitis | 001 | 1 | NIH | 11/8/2023 | -$343 |
| | 2024 | 2021 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R21ES031510 | m6A Epitranscriptomics in Toxicant Associated Steatohepatitis | 000 | 2 | NIH | 11/8/2023 | -$3,438 |
| | 2024 | 2021 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R21ES031510 | m6A Epitranscriptomics in Toxicant Associated Steatohepatitis | 000 | 2 | NIH | 11/8/2023 | -$802 |
| | 2024 | 2021 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R15GM140427 | Identifying and characterizing translation of circular RNAs using high-throughput sequencing data | 000 | 1 | NIH | 10/16/2023 | $0 |
| | 2024 | 2021 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R03HD097075 | MicroRNAs as Mediators of Birth Defects | 000 | 2 | NIH | 10/19/2023 | -$23,578 |
| | 2024 | 2021 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | 90ZT0210 | Survivors of Torture Recovery Center (STRC) | 06 | 2 | ACF | 10/27/2023 | -$204,288 |
| | 2024 | 2021 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01HL125877 | A novel mechanism of stromal cell-derived factor 1 protection against diabetic cardiomyopathy | 000 | 5 | NIH | 12/6/2023 | $0 |
| | 2024 | 2021 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01EY028188 | Understanding signal processing in retinal bipolar cell pathways | 000 | 5 | NIH | 10/12/2023 | $0 |
| | 2024 | 2021 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01AG053585 | Reversing Microvascular Dysfunction in Advancing Age | 000 | 5 | NIH | 12/4/2023 | -$2,171 |
| | 2024 | 2021 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | U18TR003787 | A Handheld Microchip for GC analysis of breath to screen for COVID-19 | 000 | 1 | NIH | 11/16/2023 | $0 |
| | 2024 | 2020 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01EY026180 | Tear Film Lipid Compositional, Structural, Functional, Relationships, and Dry Eye | 000 | 5 | NIH | 10/13/2023 | -$6,651 |
| | 2024 | 2018 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R15GM123391 | Structural Mechanisms Underlying Regulation and Substrate Specificity of Deubiquitinase A | 000 | 1 | NIH | 10/1/2023 | -$50,475 |
| | 2024 | 2018 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01DE014605 | Inter-kingdom signaling by A. actinomycetemcomitans | 000 | 16 | NIH | 10/1/2023 | -$302 |
| | 2024 | 2017 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | OT2OD024898 | Functional Mapping with Lumbosacral Epidural Stimulation for Restoration of Bladder Function After Spinal Cord Injury | 001 | 1 | NIH | 10/31/2023 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $79,684,633 ) (Continued on the next page) |
| | 2023 | 2023 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01AI148241 | Iron independent role for yersiniabactin in Yersinia pestis | 000 | 2 | NIH | 3/2/2023 | $15,780 |
| | 2023 | 2023 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | K23AA029198 | Lactobacillus rhamnosus: A Novel Probiotic Therapy for treating Alcohol Use Disorder | 000 | 3 | NIH | 4/29/2023 | $140,775 |
| | 2023 | 2023 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01AR071789 | Reversing Skeletal Muscle Myopathy by Hydrogen Sulfide | 001 | 5 | NIH | 2/23/2023 | $33,880 |
| | 2023 | 2023 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01AR071789 | Reversing Skeletal Muscle Myopathy by Hydrogen Sulfide | 000 | 5 | NIH | 2/1/2023 | $304,920 |
| | 2023 | 2023 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | P20GM125504 | Functional Microbiomics, Inflammation and Pathogenicity | 000 | 6 | NIH | 2/27/2023 | $2,347,500 |
| | 2023 | 2023 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R15ES028440 | Prenatal Cigarette Smoke Exposure: Impact on Offspring Gut Bacterial Microbiome | 000 | 2 | NIH | 3/2/2023 | $148,389 |
| | 2023 | 2023 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | U01DK074007 | U of L Clinical Center to Investigate the Pathogenesis, Etiology, and Treatment of Gastroparesis through the NIDDK Gastroparesis Consortium | 003 | 17 | NIH | 8/29/2023 | $377,701 |
| | 2023 | 2023 | UNIVERSITY OF LOUISVILLE | 300 E. Market Street, Suite 300 | Louisville | KY | 40202-1959 | JEFFERSON | USA | K0149065 | Geriatric Academic Career Awards | 00 | 1 | HRSA | 4/14/2023 | $86,978 |
| | 2023 | 2023 | UNIVERSITY OF LOUISVILLE | 300 East Market Street, Suite 300 | Louisville | KY | 40202-1959 | JEFFERSON | USA | D8746115 | Dental Faculty Loan Repayment | 01 | 2 | HRSA | 9/5/2023 | $7,000 |
| | 2023 | 2023 | UNIVERSITY OF LOUISVILLE | 300 East Market Street, Suite 300 | Louisville | KY | 40202-1959 | JEFFERSON | USA | M0142454 | Behavioral Health Workforce Education and Training Program | 00 | 3 | HRSA | 8/11/2023 | $500,000 |
| | 2023 | 2023 | UNIVERSITY OF LOUISVILLE | 300 E. Market Street, Suite 300 | Louisville | KY | 40202-1959 | JEFFERSON | USA | H6500013 | COMMUNITY BASED DENTAL PARTNERSHIP | 00 | 22 | HRSA | 6/1/2023 | $353,464 |
|
